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The appearance of specific receptors for the Ca 2+ channel antagonist nitrendipine has been followed 
during the fetal and post-natal development of rat brain without cerebellum, cerebellum, skeletal muscle 
and cardiac muscle. The number of nitrendipine r ceptors i low at the fetal stage and increases drastically 
during post-natal development of brain, cerebellum, skeletal muscle and cardiac muscle. The time course 
of this increase is different for each type of tissue studied. No significant change in receptor ligand 
dissociation constant (&) can be detected over the development period studied. The results are discussed 
in relation with the known properties of the differentiation process in the four types of excitable tissues 
studied. 
Ontogenesis Nitrendipine-receptor 
1. INTRODUCTION 2. EXPERIMENTAL 
Voltage-dependent Na+ and Ca’+ channels are 
very important structural elements of the surface 
membrane in a wide variety ‘of excitable cells 
[l-4]. They are involved in both the generation of 
action potentials and in the excitation-contraction 
or excitation-secretion coupling process in heart 
and smooth muscle on one hand or in central 
neurons and secretary systems on the other [l-5]. 
2. I. Tissue preparation 
The purpose of this work is to study with the 
radiolabeled nitrendipine, which is one of the most 
potent calcium channel blockers described until 
now [5], the ontogenesis of the Ca*+ channel in 
brain, cerebellum, skeletal muscle and cardiac 
muscle during the fetal and post-natal develop- 
ment of the rat. 
Fetal and post-natal Wistar albino rats were used 
throughout this work. Pregnant rats were killed at 
various times from 19-20 days of gestation by de- 
capitation and fetal rats taken out. Post-natal rats 
were raised in litters of 5 and killed at various times 
from l-60 days post-natal. From each animal, 
brain without cerebellum, cerebellum, leg skeletal 
muscles and heart were dissected, weighed and 
washed in ice-cold 20mM Tris-HCl buffer con- 
taining 0.25 M sucrose and 1 mM EDTA (pH 7.4) 
(TSE buffer). For skeletal muscles and hearts, 
homogenization was performed at 4°C in 10 vols of 
TSE buffer using a polytron apparatus (Brinckman 
instruments) at setting 5 with three 5-s bursts. For 
brains and cerebella, homogenization was perfor- 
med using a Teflon Potter-Elvehjem in 10~01s of 
TSE buffer at 4°C. Homogenates were washed 
twice by centrifugation at 1000 x g for 10 min 
followed by resuspension of the pellet in fresh TSE * To whom reprint requests should be sent 
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buffer to a concentration of 100 mg original tissue 
weight/ml TSE buffer. Subsequently the homo- 
genates were filtered through four layers of cheese- 
cloth. 
2.2. Binding assays 
t3H]Nitrendipine binding assays were carried 
out as follows: 0.5-l mg homogenate protein was 
equilibrated in 1 ml of the standard incubation 
medium containing 20 mM Tris-Cl, 50 mM choline 
chloride and 10m4 M of the protease inhibitor, 
phenylmethylsulfonyl fluoride (pH7.4) at 4°C in 
the absence (total binding) and in the presence 
(non specific binding) of 1 PM unlabeled nitrendi- 
pine. After incubations for 40min at 4°C binding 
was stopped by filtering in duplicate, aliquots of 
400~1 of the incubation medium through Whatman 
GF/B glass fiber filters under reduced pressure. 
Filters were rapidly washed twice (<15 s) with 5 ml 
of an ice-cold solution containing 200 mM choline 
chloride and 20 mM Tris-Cl buffer (pH 7.4). Ali- 
quots of 100~1 of the incubation mixture were 
taken for measurement of the concentration of 
[3H]nitrendipine present. All experiments were 
carried out under dim light because of the light 
sensitivity of the dihydropyridine derivative. Pro- 
tein content was determined as in [6] using bovine 
serum albumin as standard. 
3. RESULTS 
3.1. Central nervous system 
t3H]Nitrendipine has been used as a biochemical 
marker of the differentiation of the nitrendipine- 
sensitive Ca2+ channel in different excitable tissues 
of rat. The inset of fig.lA shows representative 
Scatchard plots for the specific binding of [3H]- 
nitrendipine to its receptors in rat brain without 
cerebellum. Dissociation constants (&) and maxi- 
mal number of [3H]nitrendipine binding sites 
(Bmax) are 0.48 nM and 42 fmol/mg protein and 
0.44 nM and 54 fmol/mg protein in brain homo- 
genates from 11 days and 35 days post-natal, 
respectively. Scatchard plots are linear at all stages 
of development demonstrating that [3H]nitrendi- 
pine binds to a single class of sites in the range of 
concentrations used (0.1-10 nM). The main panel 
of fig.lA presents Kd and B,, values during de- 
velopment from the fetal to adult stage. & Vahes 
remained stable at 0.42 -1- 0.03 nM throughout the 
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Fig. 1. Ontogenesis of the specific [3H]nitrendipine 
binding component in rat brain (A) and cerebellum (B). 
Insets: Scatchard plots of the specific [3H]nitrendipine 
binding on homogenates of brain (A) and cerebellum 
(B). B is bound [3H]nitrendipine expressed in fmol/mg 
protein and B/F is bound over free [‘Hlnitrendipine ex- 
pressed in nM. Main panels: evolution of the maximum 
[3H]nitrendipine binding capacity as a function of time 
in days (A) for brain (A) and cerebellum (B). & values 
(A) are obtained at each stage of development from 
Scatchard analysis. Specific binding compared to total 
binding is between 45 and 60%. 
developmental process. The maximal number of 
t3H]nitrendipine binding sites (Bmax) increased 
regularly during development from 17 days post- 
coitum (12 fmol/mg protein) to 15 days post-natal 
(to reach a plateau value at 56 fmol/mg protein): 
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B,,, values remained constant between 15 days 
post-natal and the adult stage at a value of 
56 + 3 fmol/mg protein. 
The ontogenesis of the [ 3H] nitrendipine binding 
component of the Ca*+ channel in rat cerebellum 
is shown in fig. 1B. The inset in fig. 1B shows repre- 
sentative Scatchard plots for the specific binding 
of [3H]nitrendipine to its receptor in rat cerebella 
at two stages of development. Kd and B,,, values 
are 0.42 nM and 12 fmol/mg protein and 0.53 nM 
and 34 fmol/mg protein at 2 days post-natal and 35 
days post-natal, respectively. Scatchard plots are 
linear indicating that [3H]nitrendipine binds to a 
single class of site in the range of concentrations 
used (0.1-10 nM). The main panel of fig.lB shows 
the variation of B,,, values at different stages of 
development and the corresponding Kd values. 
Values of the K,j remained constant at all stages 
studied at a value of 0.46 + 0.06 nM. B,,,,, values 
regularly increased during development from 
8 fmol/mg protein at 17 days-coitum to reach a 
plateau value at 30 days post-natal. B,,,,, values re- 
mained stable at a value of 30 + 4 fmol/mg protein 
between 30 and 60 days post-natal. 
3.2. Skeletal muscle and cardiac muscle 
The ontogenesis of the nitrendipine binding 
component of the Ca*+ channel in rat leg skeletal 
muscles is shown in fig.2A. Scatchard plots are 
shown in inset A at two stages of development. Kd 
and B,,, values are 1.6 nM and 250 fmol/mg pro- 
tein, and 1.9 nM and 4OOfmol/mg protein at 6 
days post-natal and 60 days post-natal, respec- 
tively. Variation of B,,,,, and Kd values at different 
stages of development are presented in the main 
panel of fig.2A. Scatchard plots of the specific 
[ 3H] nitrendipine binding component are linear in 
the range of concentrations used (O.l-10nM). 
B,,, values increased regularly between 17 days 
post-coitum (95 fmol/mg protein) and 15 days 
post-natal. Then B,, values remained constant 
between 15 days post-natal and the adult stage at 
a value of 416 + 20 fmol/mg protein. 
The same type of data are presented for the car- 
diac muscle in fig.2B. Representative Scatchard 
plots are shown in inset B for two stages of de- 
velopment. & and Bmax values are 0.4nM and 
75 fmol/mg protein and 0.6 nM and 175 fmol/mg 
protein at 4 days post-natal and 40 days post-natal, 
respectively. The variation of Bmax values during 
Fig.2. Ontogenesis of the [3H]nitrendipine binding com- 
ponent in rat skeletal muscles (A) and heart (B). Insets: 
Scatchard plots of specific [3H]nitrendipine binding on 
homogenates of skeletal muscles (A) and heart (B). B is 
bound [‘Hlnitrendipine expressed in fmol/mg protein 
and B/F is bound over free [3H]nitrendipine expressed 
in nM. Main panels: A and B show the evolution of the 
maximum [3H]nitrendipine binding capacity as a func- 
tion of time in days (A) for skeletal muscles (A) and 
heart (B). & values (0) are obtained at each stage of 
development from Scatchard analysis. Specific binding 
compared to total binding is between 45 and 55%. 
cardiac development and their corresponding Kd 
values are presented in main panel of fig.2B. 
Scatchard plots of the specific [3H]nitrendipine 
binding component are linear in the range of con- 
centrations used (O.l-10nM). Values for the Kd 
remained constant at all stages tudied at a value of 
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0.53 + 0.03 nM. Only B,,, varied during develop- 
ment from 50fmollmg protein at 17 days post- 
coitum to 176 + 15 fmollmg protein between 7-9 
and 60 days post-natal. 
4. DISCUSSION 
Nitrendipine has been shown to block calcium 
current or calcium-mediated processes in a variety 
of excitable cells [3,7-91 and recently specific 
receptors for the Ca2+ channel antagonist nitrendi- 
pine have been identified in brain, skeletal muscle 
and heart from adult animals [lo-121. This study 
describes the ontogenesis of specific saturable high 
affinity [3H]nitrendipine receptors in the rat brain, 
cerebellum, skeletal muscle and heart I) 
Specific receptors for the Ca*+ channel antago- 
nist nitrendipine are present in very low amounts in 
rat brain without cerebellum and cerebellum at the 
fetal stage (17-20 days post-coitum) and increase 
regularly during post-natal life. A plateau level 
corresponding to the maximal number of nitrendi- 
pine receptors is reached 15 and 30 days after birth 
in brain and cerebellum, respectively. The dissocia- 
tion constant (&) of the complex nitrendipine 
receptor does not vary during fetal and post-natal 
development. The maximal binding capacity (Max) 
remains relatively low at the adult stage at a value 
of 56 and 30fmol/mg protein in brain without 
cerebellum and cerebellum respectively, as com- 
pared to previously reported values [13] for the 
voltage-dependent Na+ channel at the same stage 
of development (1.8-2 pmol/mg protein). A com- 
parison between the results presented here and 
those previously published for the ontogenesis of 
the Na+ channel ]13] indicates that in brain the de- 
velopment of the nitrendipine-sensitive Ca*+ chan- 
nel parallels the maturation of the voltage-depen- 
dent Na+ channel. Moreover, post-natal increase 
of the nitrendipine receptor in brain is roughly 
parallel to that found for the receptors of several 
neurotransmitters like the dopamine receptor [14], 
GABA-receptor [ 151, benzodiazepine receptor [ 161 
and histamine Hi receptor [17]. 
The ontogenesis of the nitrendipine-sensitive 
Ca’+ channel in the cerebellum is different from 
that observed in the brain. The number of nitrendi- 
pine-receptors increase slowly between 17 days 
post-coitum and 4-5 weeks after birth. The post- 
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natal development of the nitrendipine receptor in 
the rat cerebelium parallels the appearance of the 
voltage-sensitive Na+ channel which also reaches a 
maximal level between 30 and 40 days after birth 
f 131. The ontogenesis of the nitrendipine receptor 
closely follows the ontogenesis of GABA receptors 
which are associated with granule cells [ 181. 
The amount of nitrendipine receptors in skeletal 
muscle increases regularly during fetal and early 
post-natal ife. A maximal number of receptors for 
nitrendipine is attained between 15 and 20 days after 
birth and remain constant to the adult stage (60 
days post-natal). As for brain without cerebellum 
and cerebellum, the affinity of the nitrendipine 
receptor complex does not vary during develop- 
ment. However, the affinity of f3H]nitrendipine 
for its receptor is slightly lower in skeletal muscle 
(1.9 -t 0.1 nM) than in central nervous system and 
cardiac muscle (0.4-0.5 nM). There is a close cor- 
relation between the chronology of the appearance 
of the nitrendipine receptor and the ontogenesis of 
the TTX-sensitive Na+ channel in rat skeletal 
muscles [131. In a previous work it has been shown 
that [3H]nitrendipine receptors are preferentially 
localized in the transverse tubule membranes of 
rabbit and frog muscle [ll]. Therefore, it is of 
interest o remark that the ontogenesis of rat skele- 
tal muscle nitrendipine receptors closely follows 
the appearance and the differentiation of the T- 
tubule and sarcoplasmic reticulum systems in the 
rat skeletal muscle during fetal and post-natal 
development [19,201. 
The rate of development of the nitrendipine-sen- 
Sjtive Ca*+ channel in the heart is different from 
that of other excitable tissues (a recent meeting 
abstract reveals the same observation for mouse 
heart [21]), with a more rapid rise in receptor 
density from 50 to 175 fmollmg protein between 
17 days post-coitum and 7 days of post-natal ife. 
The maximal number of binding sites for nitrendi- 
pine is attained between 7 and 10 days post-natal. 
At this time the number of low affinity TTX- 
sensitive Na’ channels is at the adult level [22]. In 
rat heart the presence of ,(3 receptors and of a cate- 
cholamine-mediated activation of adenylate cyclase 
have been demonstrated as early as at 13 days of 
embryonic development [23]. At that time nitren- 
dipine-sensitive Ca*+ channels are undetectable 
(not shown) and, therefore, one would not expect 
a &adrenergic activation of Ca2’ channels via 
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CAMP. Effectively at this stage of development he 
heart does not respond to catecholamines in terms 
of inotropic and chronotropic effects [23]. A 
marked increase in heart rate to catechol~ine 
appears at about 18 days post-coitum when nitren- 
dipine-sensitive Ca’+ channels are detectable and 
physiologicaIly functional [24]. 
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